ISPOR 2018 – “A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients. Stacey J, Hilderbrand S, Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...

ISPOR 2018 – “Comparison of Bleeding Events, Strokes, and Myocardial Infarcts on Warfarin or Dabigatran for Treatment of Atrial Fibrillation: Results of a Real-World Data Analysis”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a comparison of bleeding events, strokes, and myocardial infarcts on warfarin or dabigatran for treatment of atrial fibrillation: results of a real-world data analysis. Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018...

A Six-Year Approach To Improving Clinical Trial Efficiencies

May 17, 2018 | News

Clinical Leader, May 2, 2018 Learn more

Bulgaria’s Puls Hospital Aiming for Earlier Clinical Trial Involvement with TriNetX

May 15, 2018 | Press Releases

LONDON, 15 May, 2018 — Puls Hospital, the only private multi-profile hospital in the Blagoevgrad region of Bulgaria, has announced it is partnering with TriNetX to expand its participation in clinical trials by getting involved earlier in the process. “We are looking...

TriNetX to Present at ISPOR 2018 on the Use of Real-World Data as an Established Method for Evaluating Safety & Comparative Effectiveness

May 14, 2018 | Events, Press Releases

CAMBRIDGE, MA – May 14, 2018 – TriNetX™, the global health research network, today announced that it willpresent three posters on the use of real-world data from its federated electronic medical record (EMR)-based network as an established methodology for evaluating...

Somerset Partnership Seeks to Increase Patient Participation in Clinical Trials with TriNetX

Apr 25, 2018 | Press Releases

LONDON, April 25, 2018— Somerset Partnership NHS Foundation Trust, which serves a patient population of 650,000 in the south west region of the U.K., is the first integrated mental and community health trust in the NHS to join TriNetX, with the goal of expanding the...

Tufts Medical Center Joins the TriNetX Network for Enhanced Insight into their Clinical Data

Apr 18, 2018 | Press Releases

Cambridge, MA, April 18, 2018 — Tufts Medical Center (Tufts MC), a 415-bed academic medical center located in downtown Boston, has joined the TriNetX Network to enhance its clinical trial process. Tufts MC brings an additional one million patient lives to the global...

Pfizer Joins the TriNetX Global Health Research Network Formed to Improve Clinical Trial Design and Accelerate the Development of New Drugs

Apr 10, 2018 | Press Releases

Cambridge, MA, April 10, 2018 — Pfizer Inc., a world leader in clinical trial innovation, has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX’s network of healthcare organizations to support...

USC Keck School of Medicine Seeks to Increase Clinical Trial Opportunities by Joining the TriNetX Global Health Research Network

Mar 19, 2018 | Press Releases

Cambridge, MA, March 19, 2018 — The University of Southern California Keck School of Medicine, one of the preeminent research-intensive medical schools in the United States, has joined the TriNetX global health research network to help increase its clinical trial...

Boston Children’s Hospital Accelerates Data-Driven Approach to Clinical Research by Joining the TriNetX Global Health Research Network

Feb 20, 2018 | Press Releases

Cambridge, MA, February 20, 2018 — Boston Children’s Hospital, the top ranked pediatric hospital in the nation according to U.S. News and World Report, has joined the TriNetX global health research network to further its efforts at bringing a more data-driven approach...